A previous study showed that increased mRNA level of CHI3L1 could be associated with poor patient survival for glioblastoma and lower-grade astrocytoma tumors (Steponaitis et al., 2016). This evidence concerns the gene CHI3L1 and astrocytoma (excluding glioblastoma).